Scholarlink

Background <p>In Alzheimer’s disease (AD) the progressive accumulation of misfolded proteins, notably amyloid-β and hyperphosphorylated tau, initiates a cascade of metabolic and synaptic dysfunction, and ultimately neurodegeneration. These early molecular alterations interact with diffuse neurotrasmitter projection systems, contributing to cognitive and behavioural manifestations.</p> Methods <p>This study assessed baseline [<sup>18</sup>F]FDG-PET metabolism and its relationship with neurotransmitter receptor/transporter maps and cerebrospinal fluid (CSF) markers of AD neuropathology (Aβ42/Aβ40, pTau181, t-Tau), neuroaxonal (NFL), and synaptic damage (NPTX2, neurogranin) in 49 Mild Cognitive Impairment (MCI)-AD patients. Relative hypometabolism was derived by comparing [¹⁸F]FDG-PET scans of patients and 40 healthy controls. Spatial correlation coefficients between hypometabolism maps and normative cortical maps of neurotransmitter receptor/transporter density were computed and included in linear models with CSF biomarkers, adjusting for demographic and cognitive variables.</p> Results <p>Patients exhibited significant hypometabolism in bilateral temporo-parietal regions. Negative correlations emerged between hypometabolism and receptor distributions for 5-HT1A (<i>r</i> = − 0.36, <i>p</i> &lt; 0.001), D1 (<i>r</i> = − 0.15, <i>p</i> = 0.03), and mGluR5 (<i>r</i> = − 0.14, <i>p</i> = 0.02), which indicates that reduced glucose uptake in MCI-AD was mostly found in areas with normally high receptor densities. Noteworthy, CSF NPTX2 levels correlated with the co-localization of hypometabolism and 5-HT1A receptor distribution (β = 0.003, <i>p</i> = 0.038) with no significant associations for other CSF markers.</p> Conclusions <p>According to our findings, correlations between reduced glucose metabolism and specific neurotransmitter receptor densities suggest early involvement and vulnerability of these systems in MCI-AD. Moreover, the association between CSF NPTX2 and 5-HT1A receptor vulnerability indicates that synaptic dysfunction in AD may parallel serotonergic involvement, and supports CSF NPTX2 as a potential biomarker for disease staging.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cerebrospinal fluid NPTX2 and [18F]FDG PET track serotonergic vulnerability to neurodegeneration in prodromal Alzheimer’s disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月21日

查看全文
  • Federico Massa,
  • Beatrice Orso,
  • Francesca De Cesari,
  • Virginia Pelagotti,
  • Sara Garbarino,
  • Stefano Raffa,
  • Pietro Mattioli,
  • Lucia Argenti,
  • Lorenzo Lombardo,
  • Mattia Losa,
  • Giulia Bozzo,
  • Wendy Kreshpa,
  • Giulia Tomassini,
  • Alessia Panza,
  • Alessio Cirone,
  • Luigi Lorenzini,
  • Federica Bozzano,
  • Davide Visigalli,
  • Andrea Brugnolo,
  • Nicola Girtler,
  • Michele Piana,
  • Dario Arnaldi,
  • Silvia Morbelli,
  • Gianmario Sambuceti,
  • Antonio Uccelli,
  • Matteo Pardini

摘要

Background

In Alzheimer’s disease (AD) the progressive accumulation of misfolded proteins, notably amyloid-β and hyperphosphorylated tau, initiates a cascade of metabolic and synaptic dysfunction, and ultimately neurodegeneration. These early molecular alterations interact with diffuse neurotrasmitter projection systems, contributing to cognitive and behavioural manifestations.

Methods

This study assessed baseline [18F]FDG-PET metabolism and its relationship with neurotransmitter receptor/transporter maps and cerebrospinal fluid (CSF) markers of AD neuropathology (Aβ42/Aβ40, pTau181, t-Tau), neuroaxonal (NFL), and synaptic damage (NPTX2, neurogranin) in 49 Mild Cognitive Impairment (MCI)-AD patients. Relative hypometabolism was derived by comparing [¹⁸F]FDG-PET scans of patients and 40 healthy controls. Spatial correlation coefficients between hypometabolism maps and normative cortical maps of neurotransmitter receptor/transporter density were computed and included in linear models with CSF biomarkers, adjusting for demographic and cognitive variables.

Results

Patients exhibited significant hypometabolism in bilateral temporo-parietal regions. Negative correlations emerged between hypometabolism and receptor distributions for 5-HT1A (r = − 0.36, p < 0.001), D1 (r = − 0.15, p = 0.03), and mGluR5 (r = − 0.14, p = 0.02), which indicates that reduced glucose uptake in MCI-AD was mostly found in areas with normally high receptor densities. Noteworthy, CSF NPTX2 levels correlated with the co-localization of hypometabolism and 5-HT1A receptor distribution (β = 0.003, p = 0.038) with no significant associations for other CSF markers.

Conclusions

According to our findings, correlations between reduced glucose metabolism and specific neurotransmitter receptor densities suggest early involvement and vulnerability of these systems in MCI-AD. Moreover, the association between CSF NPTX2 and 5-HT1A receptor vulnerability indicates that synaptic dysfunction in AD may parallel serotonergic involvement, and supports CSF NPTX2 as a potential biomarker for disease staging.